In brief
The World Health Organization has confirmed a plateau in mpox cases in the Democratic Republic of Congo, with health officials noting a significant drop in daily infections following the introduction of vaccines. However, experts warn that the disease is still spreading in some areas and emphasize the need for ongoing vaccination and monitoring efforts.
Recent visits to the Lwiro clinic in eastern Democratic Republic of Congo (DR Congo) have revealed encouraging updates on the mpox outbreak, previously known as monkeypox. Nurse Jackson Murhula reports that the clinic now sees only two or three cases daily, down from 10 to 15 at the outbreak's height. The notable decline in new infections follows the rollout of mpox vaccinations, which received a boost from donations totaling 265,000 doses.While the World Health Organization (WHO) recognizes this improvement, experts caution that it may be premature to declare the outbreak under control. Dr. Samuel Boland of the WHO highlighted that over 96% of the world’s new mpox cases are currently concentrated in DR Congo, Uganda, and Rwanda, emphasizing the need for sustained public health interventions.In September, the BBC reported on the dire situation at the Lwiro hospital, which was then overwhelmed with patients. However, the current atmosphere is much more manageable, with healthcare workers seeing improvements in community response as individuals are seeking treatment earlier, foregoing traditional healers.Though vaccination programs have begun and received positive responses—over 50,000 people vaccinated thus far—concerns persist regarding the disproportionate impact on children, who often do not receive vaccinations themselves. Dr. Jean Kaseya from the Africa Centres for Disease Control and Prevention noted that children make up about 30% of infections in the region.Despite the hopeful statistics, Murhula remains cautious. Hospitalization numbers, while down, indicate that the disease has not been fully stabilized. Parents like Julienne Mwinja recount harrowing stories of children affected by mpox, showcasing the ongoing challenges faced by families in the region.Experts emphasize the importance of continued vigilance. Dr. Boland warned against complacency, as some areas in DR Congo may still experience escalations in infection rates. Vaccination efforts are also expanding to neighboring countries like Nigeria and Rwanda, with authorities hopeful that sustained intervention could lead to a decline in cases by early next year. As WHO officials gather data to reassess the outbreak's status, the urgency for consistent public health measures remains clear, emphasizing that while progress has been made, the threat of mpox continues to linger.
